Sana Biotechnology

Sana Biotechnology is an American biotechnology company that focuses on creating and delivering engineered cells as medicine for patients. The company was incorporated in 2018 and is headquartered in Seattle, Washington.
Sana Biotechnology stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Sana Biotechnology balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Sana Biotechnology cash flows

Report period2018 2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Sana Biotechnology multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Sana Biotechnology profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Sana Biotechnology assets
Sana Biotechnology cash flows

Sana Biotechnology dividend policy

The company doesn't provide dividend

Sana Biotechnology shares

TickerNameTypeNominal valueISINPrice
SANA:USSana BiotechnologyCommon share-US7995661045$9.15
Sana Biotechnology news
11.05.2022
Sana Biotechnology's GAAP loss for 3 months of 2022 was $31.448 million, down 5.7 times from $180.617 million in the previous year.
Source: {source} pictogram sana.gcs-web.com
Pictogram next
16.03.2022
Sana Biotechnology's GAAP loss for 2021 was $355.928 million, up 24.8% from $285.305 million in the previous year.
Source: {source} pictogram sana.gcs-web.com
Pictogram next
09.11.2021
Sana Biotechnology's GAAP loss for 9M 2021 was $245.197 million, up 42.4% from $172.135 million in the prior year.
Source: {source} pictogram sana.gcs-web.com
Pictogram next
05.08.2021
Sana Biotechnology's GAAP loss for 6 months of 2021 was $161.934 million, up 34.2% from $120.683 million in the prior year.
Source: {source} pictogram sana.gcs-web.com
Pictogram next
All Sana Biotechnology news
General information
Company nameSana Biotechnology
Tags#biotechnology, #genome
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address188 East Blaine Street Suite 400 Seattle, WA 98102 United States
Mailing address188 East Blaine Street Suite 400 Seattle, WA 98102 United States
Websiteir.sana.com
Information disclosurewww.sec.gov